Year |
Citation |
Score |
2024 |
Fotio Y, Mabou Tagne A, Squire E, Lee HL, Phillips CM, Chang K, Ahmed F, Greenberg AS, Villalta SA, Scarfone VM, Spadoni G, Mor M, Piomelli D. NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice. Nature Communications. 15: 1705. PMID 38402219 DOI: 10.1038/s41467-024-46139-5 |
0.689 |
|
2023 |
Fotio Y, Mabou Tagne A, Jung KM, Piomelli D. Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder. Psychopharmacology. PMID 37017699 DOI: 10.1007/s00213-023-06358-y |
0.652 |
|
2022 |
Mabou Tagne A, Fotio Y, Uppal PS, Piomelli D. Synergistic antinociceptive effects of concomitant NAAA and peripheral FAAH inhibition. Experimental Neurology. 357: 114194. PMID 35932800 DOI: 10.1016/j.expneurol.2022.114194 |
0.681 |
|
2022 |
Lee HL, Jung KM, Fotio Y, Squire E, Palese F, Lin L, Torrens A, Ahmed F, Mabou Tagne A, Ramirez J, Su S, Wong CR, Jung DH, Scarfone VM, Nguyen PU, et al. Frequent Low-Dose Δ-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood. Biological Psychiatry. PMID 35750512 DOI: 10.1016/j.biopsych.2022.04.017 |
0.677 |
|
2022 |
Lin L, Mabou Tagne A, Squire EN, Lee HL, Fotio Y, Ramirez J, Zheng M, Torrens A, Ahmed F, Ramos R, Plikus MV, Piomelli D. Diet-Induced Obesity Disrupts Histamine-Dependent Oleoylethanolamide Signaling in the Mouse Liver. Pharmacology. 1-10. PMID 35691287 DOI: 10.1159/000524753 |
0.653 |
|
2021 |
Mabou Tagne A, Fotio Y, Alan Springs Z, Su S, Piomelli D. Frequent Δ- tetrahydrocannabinol exposure during adolescence impairs sociability in adult mice exposed to an aversive painful stimulus. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 53: 19-24. PMID 34358818 DOI: 10.1016/j.euroneuro.2021.07.007 |
0.7 |
|
2021 |
Mabou Tagne A, Fotio Y, Ibne Rashid T, Piomelli D. . The Journal of Pharmacology and Experimental Therapeutics. PMID 34183435 DOI: 10.1124/jpet.121.000740 |
0.705 |
|
Show low-probability matches. |